Psychiatric medication in pregnancy and breastfeeding

The central principle

This is one area where general information can't give an answer. There's no single right choice that applies to everyone.

The right decision depends on the specific medication, the specific person, how severe their condition is, and the stage of pregnancy. Those pieces vary too much for a page like this to weigh them. What it can do is describe how the decision is approached. The decision itself should be made with a clinician, ideally before pregnancy or early in it, so there's time to plan rather than react.

The reason timing matters is practical. Many pregnancies are recognized several weeks in. By then, any exposure in the earliest weeks has already happened, and a rushed change made in alarm can do more harm than the medication would have. A conversation that happens before conception, or as soon as a pregnancy is known, lets a clinician choose deliberately. That might mean continuing a medication, switching to a better-studied one, adjusting the dose, or in some cases tapering off. None of those is automatically right. The point is that the choice is made with information rather than driven by fear.

Weighing the risks both ways

The natural instinct is to weigh a medication's risk against zero. That framing leaves out half the picture.

Untreated depression and anxiety during pregnancy carry their own risks. They affect the parent's wellbeing directly. They're also associated with outcomes such as preterm birth and with difficulty managing self-care, including eating well, sleeping, attending appointments, and avoiding alcohol or smoking. Severe untreated illness can make it hard to function day to day at a time when functioning matters. And the period after birth carries its own risk: untreated depression or anxiety during pregnancy is one of the stronger predictors of postpartum depression, which affects both the parent and the early relationship with the baby.

So the real comparison isn't medication versus nothing. It's treated illness versus untreated illness. A clinician weighs both sides, not just one. For someone with mild symptoms, that balance may point toward managing without medication, perhaps with therapy. For someone with a history of severe episodes, stopping a medication that's keeping them well may carry the larger risk. The same medication can be the right choice for one person and the wrong one for another.

Medication by type

Some medications are better studied in pregnancy than others, and that evidence shapes the choice. What follows stays general. It isn't a recommendation for any individual.

Among antidepressants, the SSRIs are among the more studied. Within that group, sertraline is often viewed as relatively reassuring, partly because it has a large body of evidence behind it. Paroxetine is the clear exception. It carries a specific caution, a small increased risk of certain heart-related birth defects, so it's generally avoided in pregnancy when another option is suitable. SNRIs, a related class, carry considerations broadly similar to the SSRIs. Bupropion, an antidepressant that works differently, is sometimes used, though the data on it in pregnancy is more limited. Benzodiazepines, a class of anti-anxiety and sedative medications, are generally avoided in pregnancy, particularly with regular ongoing use.

Among mood stabilizers, the picture is sharper. Valproate is generally avoided in pregnancy because it carries significant risks, including a meaningful chance of birth defects and effects on later development. Lithium and lamotrigine each carry their own considerations that a clinician weighs. Lithium has been linked to a small increased risk of certain heart defects, and lamotrigine is one of the mood stabilizers more often considered usable in pregnancy. Neither is a simple yes or no. Each is a conversation.

The point isn't to memorize any of this. It's to know that a clinician weighs medication-specific evidence rather than treating all options as the same.

Symptoms in the newborn

There's one effect worth knowing about calmly, because it sounds more alarming than it usually is. Some babies exposed to SSRIs or SNRIs late in pregnancy can have temporary adjustment symptoms in the first days after birth. These can include jitteriness, irritability, feeding or sleep difficulty, or fast breathing. In most cases the symptoms are mild and short-lived, and they settle without specific treatment. Knowing about this in advance lets the delivery team watch for it. It isn't, on its own, a reason to stop a medication that's keeping a parent well, but it's something to plan for with both the prescriber and the obstetric team.

Breastfeeding

Breastfeeding is a separate question from pregnancy, with its own evidence.

Many psychiatric medications pass into breast milk, usually in small amounts. Some are considered more compatible with breastfeeding than others, based on how much reaches the milk and what's known about effects on the infant. Sertraline, for instance, is among the antidepressants often viewed as relatively compatible. This is again medication-specific, and it's a conversation to have with a clinician, who can look at the particular medication alongside the benefits of breastfeeding for that family. A medication that was switched or stopped during pregnancy may also be reconsidered for the postpartum period, since the risk picture changes once the baby is born.

Planning ahead

The best time for this conversation is before conception. Planning ahead makes the decision deliberate rather than reactive.

If you discover a pregnancy while taking a psychiatric medication, don't stop it abruptly. Stopping suddenly can cause a relapse of the underlying condition or discontinuation symptoms, and either can leave you worse off at a vulnerable time. Talk to the prescriber instead, and ideally involve an obstetric clinician as well, so the plan reflects both the pregnancy and the mental health condition. The two clinicians working together is the situation this guide is pointing you toward.

Common questions

Is it safe to take an antidepressant while pregnant? There isn't a single yes or no, because it depends on the medication, the person, and the severity of the illness. Among antidepressants, the SSRIs are among the more studied, and some are viewed as relatively reassuring while paroxetine carries a specific caution. The risks of untreated depression and anxiety also count in the balance. This is a decision to make with a clinician for your specific situation.

Should I stop my medication if I find out I'm pregnant? Not on your own, and not abruptly. Stopping suddenly can cause a relapse or discontinuation symptoms. Contact your prescriber promptly so the medication can be reviewed deliberately. Sometimes the plan is to continue, sometimes to switch, sometimes to taper. That choice belongs with a clinician who knows your history.

Can I breastfeed while on a psychiatric medication? Often, yes, but it depends on the specific medication. Many psychiatric medications pass into breast milk in small amounts, and some are considered more compatible than others. A clinician can weigh the particular medication against the benefits of breastfeeding for your family.

Sources

This guide draws on current prescribing information and public health references. It's reviewed for clinical accuracy and updated as guidance changes.

1. National Institute of Mental Health. Mental health medications.
2. MedlinePlus, U.S. National Library of Medicine.
3. American College of Obstetricians and Gynecologists. Guidance on mental health conditions in pregnancy.